Literature DB >> 11208850

Comparison of diameter and perimeter methods for tumor volume calculation.

A G Sorensen1, S Patel, C Harmath, S Bridges, J Synnott, A Sievers, Y H Yoon, E J Lee, M C Yang, R F Lewis, G J Harris, M Lev, P W Schaefer, B R Buchbinder, G Barest, K Yamada, J Ponzo, H Y Kwon, J Gemmete, J Farkas, A L Tievsky, R B Ziegler, M R Salhus, R Weisskoff.   

Abstract

PURPOSE: Lesion volume is often used as an end point in clinical trials of oncology therapy. We sought to compare the common method of using orthogonal diameters to estimate lesion volume (the diameter method) with a computer-assisted planimetric technique (the perimeter method).
METHODS: Radiologists reviewed 825 magnetic resonance imaging studies from 219 patients with glioblastoma multiforme. Each study had lesion volume independently estimated via the diameter and perimeter methods. Cystic areas were subtracted out or excluded from the outlined lesion. Inter- and intrareader variability was measured by using multiple readings on 48 cases. Where serial studies were available in noncystic cases, a mock response analysis was used.
RESULTS: The perimeter method had a reduced interreader and intrareader variability compared with the diameter method (using SD of differences): intrareader, 1.76 mL v 7.38 mL (P < .001); interreader, 2.51 mL v 9.07 mL (P < .001) for perimeter and diameter results, respectively. Of the 121 noncystic cases, 23 had serial data. In six (26.1%) of those 23, a classification difference occurred when the perimeter method was used versus the diameter method.
CONCLUSION: Variability of measurements was reduced with the computer-assisted perimeter method compared with the diameter method, which suggests that changes in volume can be detected more accurately with the perimeter method. The differences between these techniques seem large enough to have an impact on grading the response to therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11208850     DOI: 10.1200/JCO.2001.19.2.551

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  92 in total

1.  Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

Authors:  Jaishri O Blakeley; D Gareth Evans; John Adler; Derald Brackmann; Ruihong Chen; Rosalie E Ferner; C Oliver Hanemann; Gordon Harris; Susan M Huson; Abraham Jacob; Michel Kalamarides; Matthias A Karajannis; Bruce R Korf; Victor-Felix Mautner; Andrea I McClatchey; Harry Miao; Scott R Plotkin; William Slattery; Anat O Stemmer-Rachamimov; D Bradley Welling; Patrick Y Wen; Brigitte Widemann; Kim Hunter-Schaedle; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2011-12-02       Impact factor: 2.802

2.  Assessment of intra-observer variability in measurement of high-grade brain tumors.

Authors:  James M Provenzale; Michael C Mancini
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

Review 3.  The use of tumour volumetrics to assess response to therapy in anticancer clinical trials.

Authors:  Gregory V Goldmacher; James Conklin
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

Review 4.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Authors:  Ingrid Leguerney; Nathalie Lassau; Serge Koscielny; Mélanie Rodrigues; Christophe Massard; Valérie Rouffiac; Baya Benatsou; Jessie Thalmensi; Olivia Bawa; Paule Opolon; Pierre Peronneau; Alain Roche
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

6.  Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.

Authors:  Maite Verreault; Charlotte Schmitt; Lauriane Goldwirt; Kristine Pelton; Samer Haidar; Camille Levasseur; Jeremy Guehennec; David Knoff; Marianne Labussière; Yannick Marie; Azra H Ligon; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Brian M Alexander; Patrick Y Wen; Jean-Yves Delattre; Keith L Ligon; Ahmed Idbaih
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

7.  Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.

Authors:  Tina Young Poussaint; Sridhar Vajapeyam; Kelsey I Ricci; Ashok Panigrahy; Mehmet Kocak; Larry E Kun; James M Boyett; Ian F Pollack; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2015-10-20       Impact factor: 12.300

8.  Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics.

Authors:  Shonket Ray; Rosalie Hagge; Marijo Gillen; Miguel Cerejo; Shidrokh Shakeri; Laurel Beckett; Tamara Greasby; Ramsey D Badawi
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

9.  Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.

Authors:  James S Cordova; Eduard Schreibmann; Costas G Hadjipanayis; Ying Guo; Hui-Kuo G Shu; Hyunsuk Shim; Chad A Holder
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

Review 10.  Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients.

Authors:  John H Rossmeisl; Paulo A Garcia; Gregory B Daniel; John Daniel Bourland; Waldemar Debinski; Nikolaos Dervisis; Shawna Klahn
Journal:  Vet Radiol Ultrasound       Date:  2013-11-13       Impact factor: 1.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.